Young Investigator Award in Survivorship Research

The Young Investigator Award in Survivorship Research is offered by Conquer Cancer, the ASCO Foundation, an organization dedicated to advancing cancer research and improving patient care globally. Since its founding in 1984, Conquer Cancer has distributed over 215 million dollars through more than 10500 grants and awards, supporting clinical and translational oncology research. The foundation’s mission is to accelerate breakthroughs and improve outcomes for all cancer patients while promoting survivorship and long term health after treatment. This specific funding opportunity is designed to support early career physicians transitioning from fellowship or training into faculty roles. The award focuses on survivorship research, an area that examines the long term health, quality of life, and ongoing needs of individuals who have completed cancer treatment. The program aims to both foster the development of independent clinical researchers and increase awareness of the unmet needs of cancer survivors. It is structured as a mentored award, requiring applicants to work under the guidance of an experienced mentor in the field of cancer survivorship. The funding amount for this award is 50000 dollars for a one year period, distributed in two equal installments. The funds are directed to the sponsoring institution and must primarily support research related expenses such as personnel, supplies, equipment, and travel. At least 46000 dollars must be allocated directly to research activities, with limited allowances for travel up to 1500 dollars and indirect costs capped at 2500 dollars. The funding cannot be used for tuition, professional membership dues, or reimbursable patient care costs. The project must be feasible within a one year timeline and demonstrate clearly defined and measurable outcomes. Eligibility is limited to physicians holding an MD, DO, or equivalent degree who are working in the United States in a clinical research setting. Applicants must be within specific early career stages, including final years of subspecialty training or within the first year of a faculty appointment. They must also be within 10 years of receiving their medical degree, hold a valid US medical license during the award period, and commit at least 60 percent of their time to research activities. Applicants must be members of ASCO or have applied for membership and must have a qualified mentor affiliated with their institution. There are no citizenship requirements, but applicants must ensure visa eligibility for the full project duration. The application process is conducted entirely online through the ASCO application portal. Applicants must complete multiple required components including project information, research strategy, biostatistical plan, patient impact section, budget, timeline, personal statement, biosketch, mentorship plan, and institutional approvals. Additional required documents include letters of support from mentors, a biostatistician, and where applicable, a patient advocate and drug manufacturer. The research proposal must adhere to strict formatting and page limits, and all submissions must be in English. Applications undergo a rigorous multi stage peer review process evaluating scientific merit, mentorship quality, applicant potential, and institutional support. Applications opened on July 1 2026 and must be submitted by January 28 2027 at 1159 PM Eastern Time. Additional materials may be submitted until February 18 2027. Award notifications are expected in April 2027, with the funding period running from July 1 2027 through June 30 2028. The program is recurring annually, and applicants are encouraged to begin early due to the complexity of requirements. For questions or clarification, applicants may contact the program administrators via the provided grants email address.

Ensure strong mentorship plan clear hypothesis driven proposal robust statistical design and demonstrated patient impact